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ABSTRACT 
Female gender and black race have been associated with lower use of cardiac resources 
however; these patients also have a higher prevalence of obesity. Therefore we determined 
their relation to cardiac catheterization after stress testing. Clinical characteristics were 
determined for all patients stress tested over one year at a safety-net, urban, teaching hospital. 
Subsequent cardiac catheterizations were identified. Univariate and multivariate analyses 
were performed to determine the factors associated with catheterization. 3644 patients 
underwent stress testing and 484 (13%) underwent cardiac catheterization. The population 
was 58% female, 33% black, 53% were obese and 32% lacked insurance. Obese patients 
were mostly female, disproportionately black and had more CAD risk factors. An ischemic 
stress test result was similar across all BMI categories. Obesity was not associated with 
receipt of catheterization. Although univariate analysis showed fewer catheterizations for 
female and black patients, multivariate analysis adjusting for stress data and clinical risk 
factors no longer showed this. Neither race, gender, nor obesity was associated with 
catheterization utilization when stress testing and clinical factors were considered in a center 
where financial obstacles to testing were minimized.  
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INTRODUCTION 
Obesity is a major societal concern with multiple adverse medical and cardiac implications 
(Berrington de Gonzalez et al., 2010; Flegal, Graubard, & Williamson, 2007; Wilson et al., 
2002). In addition to being associated with more cardiac risk factors, obesity poses an increased 
burden on cardiac investigations with more challenging cardiac imaging, (Finkelhor, Moallem, & 
Bahler, 2006; Lerakis et al., 2007) greater potential complications of cardiac catheterization 
(Blankenship et al., 1998; Cox et al., 2004; Ellis et al., 1996; Waksman et al., 1995) as well as 
obesity-related technical limitations of current cardiac catheterization equipment (Vanhecke, 
Berman, & McCullough, 2008; Yancy et al., 2005). Further, the influence of race and gender on 
catheterization use in the majority of studies has demonstrated reduced utilization for black and 
female populations even after adjusting for other medical and socioeconomic factors (Kressin & 
Petersen, 2001; Pearte et al., 2008). Since black and female patients are also more often obese 
(Flegal et al., 2012; MMWR, 2009) and since stress testing is often the initial test in evaluating 
patients whose symptoms could be due to coronary artery disease, we investigated the 
relationship of obesity in addition to race and gender in determining the subsequent performance 
of cardiac catheterization. 
 
METHODS 
Between July 1, 2005 and June 30, 2006 all patients referred for cardiac stress testing at an 
urban safety net, not for profit, university affiliated teaching hospital were identified. Patient 
characteristics were determined from review of the electronic patient records and stress testing 
and catheterization databases. Weight was directly measured for all inpatients while for 
outpatients it and all heights were that proffered by the patient. From this body mass index (BMI, 
kilograms divided by height in meters squared) was determined. Standard weight categories were 
used: underweight <18.5 kg/m2, normal 18.5-24.9 kg/m2, overweight 25.0-29.9 kg/m2, obese 
30.0-39.9 kg/m2 and morbidly obese ≥40.0 kg/m2. Race was recorded in the stress database by 
the nurse at the time of testing. Hypertension and hypercholesterolemia were defined by their 
presence in the electronic medical record (EMR) problem list or by a documented prescription 
for an antihypertensive or antihyperlipidemic medication on the medication list. Smoking status 
was dichotomized as current or not smoking. A history of prior coronary artery disease was 
present if any of the following were documented: a prior myocardial infarction, percutaneous 
coronary intervention, coronary artery bypass surgery or prior cardiac catheterization 
demonstrating coronary artery disease. A family history of premature coronary artery disease 
was noted if this was present in a first degree female or male relative <65 years and <55 years 
respectively. The type of insurance was obtained from the medical record and divided into 
commercial, Medicare, Medicaid or uninsured.  
Stress tests were stratified as negative or positive for ischemia or indeterminate if ischemic 
markers were equivocal, imaging was technically unacceptable or findings were negative for 
ischemia but the patient did not reach 85% of age predicted maximal heart rate on either exercise 
or dobutamine/atropine stress testing.  
All patients undergoing cardiac catheterization within the subsequent 6 months of stress 
testing in the absence of an intervening cardiac event were determined.  
Statistical analyses were performed using Statistica software version 8 (StatSoft, Tulsa, 
Oklahoma, USA) and SAS software Version 9.2 of the SAS System for Windows (SAS 
InstituteInc., Cary, North Carolina). Categorical data concerning demographics and stress testing 
26 Influence of Obesity, Race and Gender on Cardiac Catheterization after Stress Testing- Finkelhor 
 
characteristics were compared using Chi squared analysis. Continuous variables were compared 
using ANOVA. The Bonferroni correction was used when comparing results for individual 
weight categories with normal. Comparisons between those undergoing and not undergoing 
catheterization used Chi square for discrete data and the Student’s t-tests for continuous data. 
Logistic regression analysis was used to investigate the associations between obesity, race, 
gender and cardiac catheterization after adjustment for other patient characteristics. Statistical 
significance threshold was p<0.05.This study was approved by the institutional review board. 
 
RESULTS 
3692 patients underwent stress testing of which 48 were excluded from analysis: four due to 
missing BMI data and 44 with a low BMI (<18.5 kg/m2, 1.2%) as the influence of excess weight 
on test utilization was the main focuses of this study. Thus, the study population consisted of 
3644 patients. The mean age was 55.4±12.6 years, 57.9% were female, 51.1% were white, 33% 
black, and 9% Hispanic. The mean BMI was 31.9±8.0 kg/m2 (range 18.5 to 80.1 kg/m2), and 
53% were obese or morbidly obese (BMI ≥ 30 kg/m2). A total of 24.6% of patients had 
Medicare, 16.9% had Medicaid, 26.6% private insurance, and 31.9% were uninsured.  
The patient demographics broken down by BMI category are listed in Table 1. As seen in 
prior studies black and female patients were more likely to be obese: 60.2% of black patients 
versus 49.7% of white patients (p<0.001) and 58.0% of females versus 45.1% of males 
(p<0.001). Obese patients were also younger, had more coronary artery disease risk factors 
(diabetes, hypertension and elevated cholesterol) but were less likely to be smokers or have 
previously documented coronary artery disease.  
The stress results are listed in Tables 2 and 3. Treadmill exercise was performed in 56.8%, 
pharmacologic testing using either dobutamine/atropine in 29.7% or adenosine in 13.3% and 
paced stress testing in 0.2%. The vast majority of stress tests were performed using imaging 
(90.1%) most often stress echocardiography (76.9% of imaging tests). In order to optimize the 
echo wall motion assessment each increased BMI category required a significantly greater 
utilization of left heart echocardiographic contrast. The only testing indication significantly 
different between groups was a proportionately greater testing for dyspnea in the morbidly obese 
population. Despite their younger age, those obese patients able to exercise had markedly worse 
functional capacities. 
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A sizable proportion had indeterminate stress test results (17.4 %). Inadequate imaging was 
relatively uncommon accounting for only 4.8% of all tests and did not significantly differ across 
BMI categories. The major reason for an indeterminate test was the inability to achieve at least 
85% of age predicted heart rate in the absence of an ischemic marker (12.6% of the total study 
population). Inadequate heart rate response was significantly more common with exercise testing 
(21.6%) than with high dose dobutamine/atropine stress testing up to 40 mcg/kg/min and 1.0 mg 
respectively (14.1%, p<0.001). These results were most likely due to beta-blockade as an 
inadequate heart rate response without ischemic markers occurred in 12.5% without beta-
blockers versus 33.7% on them (p<0.001), which are not routinely held prior to testing in our 
lab. Beta-blocker use was relatively constant between the BMI groups.  
Cardiac catheterization was performed in 13.3% of the total population: 62.6% of those with 
an ischemic response, 25.4% of those with an indeterminate response and in 7.1% of those with 
negative tests. Broken down by gender, race and BMI (dichotomized at 30 kg/m2) a significantly 
greater percentage of those undergoing catheterization were male (16.2% versus 11.1%, 
p<0.001) and white (15.0% versus 10.2%, p<0.001) but there was no significant difference for 
obesity (14.0% versus 12.5%, p=0.18). As expected, multiple cardiac risk factors were also 
significantly different between groups. Multivariate analysis showed that race, gender and BMI 
were not associated with catheterization after the stress test results, standard CAD risk factors 
and prior known CAD were included (Table 5). Repeating this analysis only for those without 
known prior CAD showed similar results. 
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DISCUSSION 
In a population of patients referred for cardiac stress testing at one urban safety-net hospital, 
obese patients differed in many ways from non-obese patients including a younger age, greater 
proportion of blacks, females, diabetes, hypertension and hypercholesterolemia but fewer 
smokers. Obese patients also required more pharmacologic stress testing and those undergoing 
echocardiographic imaging required more use of left heart intravenous contrast. Despite these 
differences obese patients had similar rates of ischemic stress test response and indeterminate 
test results due to either inadequate imaging or the inability to reach the minimal heart rate 
threshold for an adequate negative test. Although univariate analysis suggested an association 
between catheterization and race and gender, but not BMI, this association vanished when 
standard cardiac risk factors were included in multivariate analysis.  
The lack of a multivariate race and gender effect on testing is concordant with recent data 
suggesting progress, in part due to a greater national awareness of treatment disparities and a 
push for institutional quality and accountability (Cohen et al., 2010; Lewis et al., 2009). Serial 
trends for the AHA Get with the Guidelines benchmark therapies for acute coronary syndromes 
have shown continued improvement in participating hospitals, attenuating race and gender 
differences with time (Lewis et al., 2009). We have been a participant in this program and were 
included in these reports. Even though stress testing was not one of the items they assessed it is 
possible that the push for evidence based care such a program fosters extends beyond those 
benchmarks being addressed.  
Fewer patient or physician financial concerns could also explain our results. Prior studies 
have shown that black patients were more often uninsured than white, which we also found 
(33.6% black versus 23.5% white patients were uninsured, p=0.002). Paradoxically uninsured 
status was associated with greater cardiac catheterization utilization in the multivariate analysis 
(Table 5). As a county owned entity, patients that do not have insurance are rated to pay only a 
scaled amount of the testing costs based on their income. Further, at the time of this study all 
physicians were salaried hospital employees. These could reduce patient financial barriers and 
reluctance to undergo expensive but indicated testing as well as removing any subconscious 
physician disincentive for underinsured patients.  
Little prior information exists regarding potential biases after stress testing which might 
influence subsequent cardiac catheterization utilization. Shaw et al examined a selected 
population of patients undergoing nuclear stress testing in the late 1980’s for gender differences 
in subsequent test utilization, including cardiac catheterization. They found a similar high rate of 
positive stress tests for female (20%) and for male patients (22%) but a significant disparity in 
subsequent testing in these positive tests (38% for female and 62% for males). Further, the lack 
of additional investigation was associated with worse subsequent cardiovascular outcomes (Shaw 
et al., 1994). We are unaware of similarly derived information concerning race or obesity or in a 
more contemporary practice environment.  
As stress testing may occur early in the diagnostic cascade, race and/or gender inequities may 
exist at this point. Such disparities have been demonstrated for gender in Olmsted County (Roger 
et al., 1998), and for both race and gender using an ambulatory care national database (Cohen, 
Stafford, & Misra, 1999), and the Medicare database (Lucas et al., 2007). Further, Lucas et al 
reported the temporal trends for stress testing and cardiac catheterizations from this Medicare 
database. Stress tests and in particular those with imaging, increased at a faster rate than cardiac 
catheterizations over time across race and gender but rose less rapidly for females and blacks 
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than non-blacks and males. They were unable to infer what proportion of patients undergoing 
stress testing went on to catheterization as an unknown amount of the catheterizations bypassed 
stress testing (Lucas et al., 2006).  
We are unaware of any information on how obesity might affect any race or gender 
differences in the evaluation process. Practical equipment weight limitations remain an issue as 
our catheterization table’s maximum capacity is 450 pounds (204 kg). Despite the large number 
of morbidly obese patients in our study only three exceeded the catheterization table weight 
limit, none of whom had an ischemic stress test.  
Our study had an appreciable number of stress tests that were reported as indeterminate 
(17.4%). This was not due to obesity as there was no trend to more of these with increasing BMI. 
Further, inadequate imaging was not more common with increasing BMI, mostly due to our 
primary reliance on echocardiographic imaging and a greater protocol guided utilization of 
echocardiographic contrast with increasing BMI (Finkelhor et al., 2000). The major reason for an 
indeterminate test was failure to achieve at least 85% of age predicted heart rate in the absence of 
an ischemic marker. This too was not related to BMI but may be more a function of beta-blocker 
utilization. In an asymptomatic population undergoing exercise stress testing and not taking beta-
blockers only 7% would fail to reach 85% of traditional age predicted maximal heart rate (Gulati 
et al., 2010). Our practice was not to withdraw beta-blockers prior to testing (Fletcher et al., 
2001).  
This study has several limitations. It was retrospective and from a single institution. We were 
unable to infer what biases, if any, may have occurred prior to stress test referral. Despite our 
study’s modest size it may have lacked power to detect a small effect of race or gender on the 
rate of post-stress test catheterization. We did not categorize ischemic stress test results into 
degrees of abnormality which might further differentiate single vessel from multi-vessel disease 
and may have further influenced progression on to cardiac catheterization. 
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